By RJ Vogt ( April 11, 2018, 8:30 PM EDT) -- Ropes & Gray LLP is advising Alexion Pharmaceuticals Inc. in its proposed $855 million acquisition of Wilson Therapeutics, a Swedish developer of therapies for patients with rare copper-mediated disorders that's being led in the deal by Vinge, according to statements released on Tuesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.